FindTrial
Sign In

The clinical research of Xijiao Dihuang Decoction on the effect of glucose metabolism reprogramming in patients with sepsis

The clinical research of Xijiao Dihuang Decoction on the effect of glucose metabolism reprogramming in patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012670
Enrollment
Unknown
Registered
2017-09-14
Start date
2017-09-20
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Interventional group:Xijiaodihuang decoction
Controlled group:Xijiaodihuag decoction, 1/10 dose

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patient with sepsis and/or septic shock; 2. aged from 18 to 80 years; 3. acute illness phase, within 2 days; 4. patients or relatives consent to the trial.

Exclusion criteria

Exclusion criteria: 1. patients without sepsis or septic shock; 2. use other therapies that restrain the release of inflammatory mediators and lactate; 3. patiens with gestation or in suckling period; 4. Exist severe disease such as AHF, ARF, etc.; 5. Consent was not accquired; 6. Abuse of alcohol and drugs; 7. Failure to follow up; 8. Allergic physique; 9. Paticipate other clinical trials.

Design outcomes

Primary

MeasureTime frame
28-day mortality;—

Secondary

MeasureTime frame
IL-1;IL-6;TNF-a;PKM2;HK;glucose;lactate;—

Countries

China

Contacts

Public ContactLu Jun

Affiliated Hospital of Nanjing University of Chinese Medicine

aztec0403@sina.com+86 17705184082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026